Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC) Grant
Funding Amount
C $50,000 - C $300,000
Deadline
Deadline not published
Grant Type
Foundation
Overview
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)
Overview
This competitive grant offering seeks to optimize the care of patients with muscle invasive bladder cancer (MIBC).
Project Types and Area of Interest
This RFP seeks solutions for the optimization of care of patients with muscle invasive bladder cancer (MIBC). Ideally, these projects will address important care gaps to facilitate the integration of perioperative treatments, have shortterm impact, have the ability to benefit community clinical practices, and/or involve multi-institution collaborations. This may include, but is not limited to solutions for:
- Reducing waiting times in the MIBC patient journey
Developing clear and efficient referral pathways in patients diagnosed with MIBCImplementing flexible multidisciplinary care models in low-resource settings, either within a single institution or through collaborative multiinstitutional partnershipsOptimizing patients before cystectomy (health, lifestyle)
Establishing non-MD-led adverse events (AE) management clinics (the physician is involved, but the clinic is managed by another healthcare professional)
What The Pfizer Foundation Inc actually gave
Source: IRS Form 990-PF, 2024
- Grants in 2024
- 9,306
- Total given
- $23.24M
Focus Areas & Funding Uses
Fields of Work
- Healthcare
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Bronchoscopy Research Grant
Intuitive Foundation
Amount
Up to US $75,000
Deadline
January 4, 2027
Listed date — confirm with the funder
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma Grant
The Pfizer Foundation Inc
Amount
US $50,000 - US $200,000
Deadline
Deadline not published
Pfizer Clostridioides difficile (C. difficile) Research Collaboration Grant
The Pfizer Foundation Inc
Amount
Up to US $500,000
Deadline
Deadline not published
Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC) Grant
The Pfizer Foundation Inc
Amount
US $150,000 - US $250,000
Deadline
Deadline not published
RD Global Monitoring anti-TFPI RES
The Pfizer Foundation Inc
Amount
Varies
Deadline
Deadline not published
Independent Medical Education Grant - Annual Meetings
The Pfizer Foundation Inc
Amount
Varies
Deadline
Deadline not published
Ready to apply for Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC) Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC) Grant. Now let's win it.